References
Tobin G, Thunberg U, Johnson A, Thorn I, Soderberg O, Hultdin M et al. Somatically mutated Ig V(H)3–21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 2262–2264.
Tobin G, Thunberg U, Johnson A, Eriksson I, Soderberg O, Karlsson K et al. Chronic lymphocytic leukemias utilizing the VH3–21 gene display highly restricted Vlambda2–14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003; 101: 4952–4957, Epub 2003 Feb 13.
Kienle D, Krober A, Katzenberger T, Ott G, Leupolt E, Barth TF et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003; 102: 3003–3009, Epub 2003 Jul 03.
Walsh SH, Thorselius M, Johnson A, Soderberg O, Jerkeman M, Bjorck E et al. Mutated VH genes and preferential VH3–21 use define new subsets of mantle cell lymphoma. Blood 2003; 101: 4047–4054, Epub 2003 Mar 13.
Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184.
Acknowledgements
This work has been supported by the ‘Wellcome Trust’ and the ‘Bournemouth Leukaemia fund’.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Davis, Z., Ibbotson, R., Wiseman, C. et al. Novel technique to facilitate the rapid identification of CLL patients utilising the VH3–21 gene. Leukemia 18, 872 (2004). https://doi.org/10.1038/sj.leu.2403290
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403290
- Springer Nature Limited